NHRA licences "Foundayo" for obesity treatment (GDNonline.com) - Sep 23, 2026 - "The licensing allows 'Foundayo' to enter the Bahraini market through pharmacies, provided it is used according to approved medical guidelines and following the necessary medical consultation, ensuring its safe use based on the patient's health condition...The approval of the medication represents an important step in expanding obesity treatment options and addressing related health challenges, in line with global developments in the treatment of obesity and associated chronic diseases."
Approval • Obesity
|